JPS5686156A - Alkylurea derivative for treating fat metabolism disease and its manufacture - Google Patents

Alkylurea derivative for treating fat metabolism disease and its manufacture

Info

Publication number
JPS5686156A
JPS5686156A JP15603280A JP15603280A JPS5686156A JP S5686156 A JPS5686156 A JP S5686156A JP 15603280 A JP15603280 A JP 15603280A JP 15603280 A JP15603280 A JP 15603280A JP S5686156 A JPS5686156 A JP S5686156A
Authority
JP
Japan
Prior art keywords
manufacture
fat metabolism
metabolism disease
treating fat
alkylurea derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15603280A
Other languages
Japanese (ja)
Inventor
Katsube Hansuuyoahimu
Kurauze Hansuupeetaa
Jitsuto Riyudeigaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5686156A publication Critical patent/JPS5686156A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Indole Compounds (AREA)
JP15603280A 1979-11-09 1980-11-07 Alkylurea derivative for treating fat metabolism disease and its manufacture Pending JPS5686156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792945238 DE2945238A1 (en) 1979-11-09 1979-11-09 N-aminocarbonyl or thiocarbonyl fused heterocyclic cpds. - useful for treating diseases of lipid metabolism

Publications (1)

Publication Number Publication Date
JPS5686156A true JPS5686156A (en) 1981-07-13

Family

ID=6085549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15603280A Pending JPS5686156A (en) 1979-11-09 1980-11-07 Alkylurea derivative for treating fat metabolism disease and its manufacture

Country Status (2)

Country Link
JP (1) JPS5686156A (en)
DE (1) DE2945238A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1542278A (en) * 1966-11-05 1968-10-11 Bayer Ag Heterocyclic compounds
DE2802630A1 (en) * 1977-01-27 1978-08-03 Abic Ltd 6-ETHOXY-1,2-DIHYDRO-2,2,4-TRIMETHYLCHINOLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1542278A (en) * 1966-11-05 1968-10-11 Bayer Ag Heterocyclic compounds
DE2802630A1 (en) * 1977-01-27 1978-08-03 Abic Ltd 6-ETHOXY-1,2-DIHYDRO-2,2,4-TRIMETHYLCHINOLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
DE2945238A1 (en) 1981-05-21

Similar Documents

Publication Publication Date Title
JPS5616411A (en) Drug for treating lipid metabolism disease
DE3068162D1 (en) Synthetic fur and process for preparation thereof
YU302580A (en) Process for producing agricultural carbamides and isocarbamides
JPS55136223A (en) Brain metabolism obstruction treating agent
ZA77786B (en) Fat process and composition
GB2127035B (en) Fryer oil treatment process
PH19294A (en) Treatment method
GB2020269A (en) Cycloalkylatriazoles and process for obtaining same
JPS54113409A (en) Treating agent for hyperlipoid disease
GB2047536B (en) Dihydroxycholecalciferols for use in regulating bone metabolism
IL56612A0 (en) 1-aryloxy-4-nitratoalkylamino-2-propanols and process for their preparation
ZA807166B (en) Low-fat spread and process
ZA79264B (en) 2h-benzofuran-3-one-derivatives and process for their preparation
GB2044267B (en) Vitamin d3 derivative and process for preparing the same
JPS5692818A (en) Parasiteestuck warmmblooded animal novel treatment
GB2066039B (en) Low-fat spread and process
JPS53130433A (en) Composition and method for treating hyperchromocyte skin disease
GB2205849B (en) Low fat spread and process for producing same
IL56895A0 (en) Phenoxyalkylamines and process for their preparation
JPS5630918A (en) Medical composition for skin disease
JPS5663353A (en) Bed for treatment
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
GB2041374B (en) Halogenated -lactam compounds and process for their preparation
IL59882A0 (en) Alkoxyalkylidenehydrazino-pyridazines and process for their preparation
JPS5686156A (en) Alkylurea derivative for treating fat metabolism disease and its manufacture